MF
OBIO icon

Magnetar Financial’s Orchestra BioMed OBIO Stock Holding History

Magnetar Financial’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,556
Closed -$414 – 1459
2022
Q2 		$414 Buy
41,556
+258
+0.6% +$2.56K ﹤0.01% 1185
2022
Q1 		$409K Hold
41,298
– – ﹤0.01% 946
2021
Q4 		$413K Buy
41,298
+671
+2% +$6.61K ﹤0.01% 1005
2021
Q3 		$402K Buy
40,627
+6,489
+19% +$64.1K ﹤0.01% 940
2021
Q2 		$348 Buy
34,138
+2,036
+6% +$21.1K ﹤0.01% 987
2021
Q1 		$361K Buy
32,102
+400
+1% +$4.87K ﹤0.01% 891
2020
Q4 		$406K Buy
31,702
+6,702
+27% +$76.4K 0.01% 589
2020
Q3 		$275K Buy
+25,000
New +$281K ﹤0.01% 550

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Magnetar Financial's OBIO Position: Q3 2022 in Review

Magnetar Financial sold out of Orchestra BioMed (OBIO) in Q3 2022, closing a stake of 41,556 shares — an estimated $414 sold.

Magnetar Financial first reported a position in OBIO in Q3 2020 and held it in 8 quarters. The position peaked at $413K in Q4 2021. 23 funds tracked by Wall St. Rank hold OBIO as of Q3 2022.

  • Magnetar Financial reported no remaining Orchestra BioMed position as of Q3 2022 after selling out during the quarter.
  • Magnetar Financial sold 41,556 Orchestra BioMed shares in Q3 2022, an estimated $414.
  • Magnetar Financial first reported a position in Orchestra BioMed in Q3 2020 and held it in 8 quarters.
  • Magnetar Financial's Orchestra BioMed position peaked at $413K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.